Min‐Bin Chen

3.0k total citations · 1 hit paper
83 papers, 2.4k citations indexed

About

Min‐Bin Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Min‐Bin Chen has authored 83 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 27 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Min‐Bin Chen's work include PI3K/AKT/mTOR signaling in cancer (9 papers), RNA modifications and cancer (7 papers) and Metabolism, Diabetes, and Cancer (6 papers). Min‐Bin Chen is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (9 papers), RNA modifications and cancer (7 papers) and Metabolism, Diabetes, and Cancer (6 papers). Min‐Bin Chen collaborates with scholars based in China, United States and Belgium. Min‐Bin Chen's co-authors include Pei‐Hua Lu, Xiao‐Yang Wu, Mu-Xin Wei, Chaoying Liu, Wei Shen, Li-Na Zhou, Ping Zeng, Zhi-qing Zhang, Wenxiang Shen and Jin‐Hua Gu and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Min‐Bin Chen

77 papers receiving 2.4k citations

Hit Papers

Crosstalk between ferroptosis and cuproptosis: From mecha... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min‐Bin Chen China 30 1.5k 697 624 334 293 83 2.4k
Jiří Ehrmann Czechia 24 1.3k 0.9× 777 1.1× 655 1.0× 200 0.6× 284 1.0× 113 2.6k
Francesco Dituri Italy 23 1.4k 1.0× 788 1.1× 692 1.1× 231 0.7× 272 0.9× 62 2.5k
Lixia Xu China 30 1.6k 1.1× 622 0.9× 966 1.5× 245 0.7× 399 1.4× 106 2.8k
Josefa Castillo Spain 20 946 0.6× 683 1.0× 512 0.8× 304 0.9× 331 1.1× 55 2.1k
Jeonghoon Heo South Korea 16 1.4k 0.9× 517 0.7× 763 1.2× 389 1.2× 351 1.2× 33 2.6k
Go J. Yoshida Japan 21 1.5k 1.0× 931 1.3× 949 1.5× 221 0.7× 313 1.1× 25 2.5k
Stefano Caruso France 28 969 0.7× 471 0.7× 687 1.1× 292 0.9× 330 1.1× 55 1.9k
Stephan Singer Germany 28 1.2k 0.8× 458 0.7× 468 0.8× 279 0.8× 201 0.7× 76 2.1k
Antonio Mazzocca Italy 30 1.4k 1.0× 815 1.2× 691 1.1× 660 2.0× 214 0.7× 86 3.0k
Akiko Kokubu Japan 25 2.2k 1.5× 649 0.9× 594 1.0× 230 0.7× 404 1.4× 29 3.0k

Countries citing papers authored by Min‐Bin Chen

Since Specialization
Citations

This map shows the geographic impact of Min‐Bin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min‐Bin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min‐Bin Chen more than expected).

Fields of papers citing papers by Min‐Bin Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min‐Bin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min‐Bin Chen. The network helps show where Min‐Bin Chen may publish in the future.

Co-authorship network of co-authors of Min‐Bin Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Min‐Bin Chen. A scholar is included among the top collaborators of Min‐Bin Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min‐Bin Chen. Min‐Bin Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Siqi, et al.. (2025). Curcumin in colorectal cancer: mechanistic insights, pharmacological limitations, and translational perspectives. Frontiers in Pharmacology. 16. 1667731–1667731.
2.
Zhang, Yan, Wenxiang Shen, Ping Li, Min‐Bin Chen, & Li-Na Zhou. (2025). Serum Interleukin Levels Predict Occurrence of Acute Radiation Pneumonitis and Overall Survival in Thoracic Tumours. Clinical and investigative medicine. 48(1). 29–38.
3.
Chen, Min‐Bin, Weiwei Sang, Lu Ke, et al.. (2024). A dual-radiomics model for overall survival prediction in early-stage NSCLC patient using pre-treatment CT images. Frontiers in Oncology. 14. 1419621–1419621. 1 indexed citations
4.
Yao, Jin, Shuofei Yang, Zhi-qing Zhang, et al.. (2022). The requirement of phosphoenolpyruvate carboxykinase 1 for angiogenesis in vitro and in vivo. Science Advances. 8(21). eabn6928–eabn6928. 39 indexed citations
5.
Shan, Huajian, Ce Shi, Min‐Bin Chen, et al.. (2022). Identification of Gαi3 as a promising target for osteosarcoma treatment. International Journal of Biological Sciences. 18(4). 1508–1520. 25 indexed citations
7.
Zhang, Yan, Jun Jin, Min Tang, et al.. (2022). Prognostic Nutritional Index Predicts Outcome of PD‐L1 Negative and MSS Advanced Cancer Treated with PD‐1 Inhibitors. BioMed Research International. 2022(1). 6743126–6743126. 8 indexed citations
8.
Wang, Le, et al.. (2021). Identification of phosphoenolpyruvate carboxykinase 1 as a potential therapeutic target for pancreatic cancer. Cell Death and Disease. 12(10). 918–918. 23 indexed citations
9.
Yin, Yuzhen, Hui Yang, Zhuo Liu, et al.. (2020). Studies on the Safety and Efficacy of Pyrotinib in the Treatment of HER2- Positive Advanced Solid Tumors Excluding Breast Cancer. Cancer Management and Research. Volume 12. 13479–13487. 17 indexed citations
10.
Zheng, Jiangnan, Yan Zhang, Shang Cai, et al.. (2020). MicroRNA-4651 targets bromodomain-containing protein 4 to inhibit non-small cell lung cancer cell progression. Cancer Letters. 476. 129–139. 26 indexed citations
11.
Zhong, Ning, et al.. (2019). TRIB3 promotes lung cancer progression by activating β-catenin signaling. European Journal of Pharmacology. 863. 172697–172697. 31 indexed citations
12.
Chen, Min‐Bin, Zhaoyu Xing, Zhi-qing Zhang, et al.. (2018). Itraconazole-Induced Inhibition on Human Esophageal Cancer Cell Growth Requires AMPK Activation. Molecular Cancer Therapeutics. 17(6). 1229–1239. 32 indexed citations
13.
Chen, Min‐Bin & Damian A. Laber. (2018). Metastatic Microcystic Adnexal Carcinoma with DNA Sequencing Results and Response to Systemic Antineoplastic Chemotherapy. Anticancer Research. 37(9). 5109–5111. 17 indexed citations
14.
Zeng, Ping, Peng Zhang, Li-Na Zhou, et al.. (2016). TMPRSS4 as an emerging potential poor prognostic factor for solid tumors: A systematic review and meta-analysis. Oncotarget. 7(46). 76327–76336. 8 indexed citations
15.
Li, Ya, et al.. (2016). Preclinical study of cinobufagin as a promising anti-colorectal cancer agent. Oncotarget. 8(1). 988–998. 36 indexed citations
16.
Cai, Xun, Min‐Bin Chen, Tiening Zhang, et al.. (2015). Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo. Journal of Experimental & Clinical Cancer Research. 34(1). 94–94. 74 indexed citations
17.
Chen, Min‐Bin, et al.. (2014). Prognostic value of TROP2 expression in patients with gallbladder cancer. Tumor Biology. 35(11). 11565–11569. 23 indexed citations
18.
Chen, Min‐Bin, Mu-Xin Wei, Junyi Han, et al.. (2013). MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer. Cellular Signalling. 26(1). 102–109. 84 indexed citations
19.
Wang, Liqiang, Wei Shen, Lan Xu, et al.. (2012). The association between polymorphisms in the leptin receptor gene and risk of breast cancer: a systematic review and pooled analysis. Breast Cancer Research and Treatment. 136(1). 231–239. 18 indexed citations
20.
Chen, Min‐Bin, Xiao‐Yang Wu, Guo‐Qing Tao, et al.. (2012). Perifosine sensitizes curcumin‐induced anti‐colorectal cancer effects by targeting multiple signaling pathways both in vivo and in vitro. International Journal of Cancer. 131(11). 2487–2498. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026